MyAir Inc

MyAir Inc is a Health Care startup based in the United States, founded in 2014. The company's slogan, "Non-invasive medical respiratory sensors for 24/7 monitoring, providing physicians data for critical patient care," encapsulates its primary focus. MyAir's flagship product, Airgo™, is a patented and CE certified non-invasive proxy for spirometry, sleep disorder screening, and ICU respiratory pattern detection. The product's versatility extends to Covid-19 critical patient care and management, particularly in respiratory distress monitoring for ARDS. MyAir's expertise lies in strategic respiration dynamics monitoring during sleep and daytime activity, delivering precise breath metrics, automated scoring, and early indications of respiratory distress.

With its focus on crucial and timely healthcare solutions, MyAir is actively involved in assisting physicians in remote monitoring of Covid-19 patients. Although specific information about the last investment and investors is currently unavailable, the company's dedication to advancing respiratory care and its niche expertise in non-invasive medical respiratory sensors position it as a compelling prospect for potential investors.